19.06.2023 LANXESS Aktiengesellschaft  DE0005470405

EQS-Adhoc: LANXESS Aktiengesellschaft: Results for Q2 and FY 2023 estimated below market expectations


 

EQS-Ad-hoc: LANXESS Aktiengesellschaft / Key word(s): Profit Warning
LANXESS Aktiengesellschaft: Results for Q2 and FY 2023 estimated below market expectations

19-Jun-2023 / 19:32 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


         

Ad hoc according to Art. 17 paragraph 1 MMVO

 

LANXESS: Results for Q2 and FY 2023 estimated below market expectations

Specialty chemicals company LANXESS expects second quarter 2023 EBITDA pre exceptionals to remain below average market expectations. Therefore, the company adjusts the outlook for FY 2023 downward as well.

EBITDA pre exceptionals for the second quarter 2023 is expected to amount to around EUR 100 million which is below current average market expectations.

Generally very weak demand combined with continued customer de-stocking effects already seen in the first quarter lasted into the second quarter and are ongoing. Especially demand weakness in the construction industry, electro/electronics and even from usually stable consumer related products, burden utilization and earnings. A recovery within the month of June is not visible.

LANXESS had formerly expected Q2 2023 EBITDA pre exceptionals roughly on par with Q1 results and a FY 2023 EBITDA pre exceptionals between EUR 850-950 million.

LANXESS now expects the weakness to continue in the second half of 2023. Hence, the company also adjusts its full-year expectations. Should trading not pick up, LANXESS now expects a profitability level of EUR 600 to 650 million EBITDA pre exceptionals for FY 2023.

LANXESS will release its results for the second quarter 2023 on August 4, 2023.

Cologne, 19 June 2023

Forward-Looking Statements
This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions, contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accept any liability whatsoever arising directly or indirectly from the use of this document.

Contact:
Eva Frerker

LANXESS AG
Head of Investor Relations

Kennedyplatz 1
50569 Köln, Deutschland
Telefon: +49 221 8885-5249
Fax: +49 221 8885-4944
E-Mail: [email protected]


End of Inside Information

19-Jun-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: LANXESS Aktiengesellschaft
Kennedyplatz 1
50569 Cologne
Germany
Phone: +49 (0)221 8885-3494
Fax: +49 (0)221 8885-4944
E-mail: [email protected]
Internet: www.lanxess.com
ISIN: DE0005470405
WKN: 547040
Indices: MDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1660673

 
End of Announcement EQS News Service

1660673  19-Jun-2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1660673&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 6.530,00 7.197,00 6.802,00 6.104,00 7.557,00 8.088,00 6.714,00
EBITDA1,2 709,00 935,00 910,00 757,00 863,00 826,00 328,00
EBITDA-Marge3 10,86 12,99 13,38 12,40 11,42 10,21
EBIT1,4 299,00 504,00 407,00 253,00 350,00 280,00 -668,00
EBIT-Marge5 4,58 7,00 5,98 4,14 4,63 3,46 -9,95
Jahresüberschuss1 124,00 523,00 191,00 902,00 267,00 251,00 444,00
Netto-Marge6 1,90 7,27 2,81 14,78 3,53 3,10 6,61
Cashflow1,7 868,00 586,00 643,00 585,00 407,00 159,00 838,00
Ergebnis je Aktie8 0,95 4,71 2,32 10,22 3,09 2,90 5,13
Dividende8 0,80 0,90 0,95 1,00 1,05 1,05 0,70
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: PricewaterhouseCoopers

INVESTOR-INFORMATIONEN
©boersengefluester.de
Lanxess
WKN Kurs in € Einschätzung Börsenwert in Mio. €
547040 25,770 Halten 2.225,14
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
11,50 16,13 0,71 7,38
KBV KCV KUV EV/EBITDA
0,50 2,66 0,33 15,97
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
1,05 0,10 0,39 24.05.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
08.05.2024 09.08.2024 07.11.2024 14.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
1,95% 0,50% -9,16% -30,09%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu LANXESS Aktiengesellschaft  ISIN: DE0005470405 können Sie bei EQS abrufen


Chemie , 547040 , LXS , XETR:LXS